• column
  • column
    • Home
    • About Us
      • Our vision
      • Our team
      • Our founders
      • News & Resources
      • Case Studies
      • Clients
      • Advisory board
  • column
    • Our Services
      • How we work
      • Project partners
    • Preclinical Research Services
    • Clinical Trial Volunteer Opportunities
    • Clinical Trials Services
  • column
    • Contact
      • Companies
      • Volunteers
    • FOLLOW US
      • Twitter
      • Linkedin
      • Facebook
Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials

Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials

by Virtus | Jul 2, 2025

LONDON – VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa...
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations.

Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations.

by Virtus | Dec 6, 2019

Click the button below to read more about this.
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.

Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.

by Virtus | Dec 6, 2019

Click the button below to read more about this.
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.

by Virtus | Nov 6, 2019

Click the button below to read more about this.
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production.

Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production.

by Virtus | Nov 3, 2019

Click the button below to read more about this.
« Older Entries

Recent Posts

    Recent Comments

    No comments to show.

    Privacy Notice and Cookie Policy

    
    
    

    All content © 2022 Virtus Respiratory Research. All Rights Reserved.

    Contact